Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Carboplatin for First Relapsed Platinum-Sensitive Ovarian Cancer
NCT00217568Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- May 2005
- Primary completion
- Mar 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, carboplatin in ovarian epithelial cancer, primary peritoneal cancer (PPC), sponsored by Fred Hutchinson Cancer Center. Started May 2005; status: completed.
02
Drugs
docetaxelcarboplatin
03
Conditions
ovarian epithelial cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00217568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00217568.